Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,261,183 papers from all fields of science
Search
Sign In
Create Free Account
Immune Complex Diseases
Known as:
Disease, Immune Complex
, Immune Complex Diseases [Disease/Finding]
, Hypersensitivities, Type III
Expand
Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Broader (2)
Autoimmune Diseases
Immediate hypersensitivity
Hypersensitivity reaction mediated by immune complex
Immune complex
In Blood
Microbiological
Expand
Narrower (1)
Serum Sickness
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
A. Tzioufas
,
M. Voulgarelis
Baillière's Best Practice & Research : Clinical…
2007
Corpus ID: 22006196
Highly Cited
2003
Highly Cited
2003
Monoclonal gammopathy: significance and possible causality in renal disease.
P. Paueksakon
,
M. Revelo
,
R. Horn
,
S. Shappell
,
A. Fogo
American Journal of Kidney Diseases
2003
Corpus ID: 40818816
Highly Cited
2001
Highly Cited
2001
Autoimmunity versus horror autotoxicus: The struggle for recognition
A. Silverstein
Nature Immunology
2001
Corpus ID: 10275131
Historical insight: Paul Ehrlich's dictum of horror autotoxicus and the changing orientation of the field inhibited acceptance of…
Expand
Highly Cited
1999
Highly Cited
1999
Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
T. Heller
,
M. Hennecke
,
+8 authors
Jörg Köhl
Journal of Immunology
1999
Corpus ID: 12424350
A C5a-receptor antagonist was selected from human C5a phage display libraries in which the C terminus of des-Arg74-hC5a was…
Expand
Review
1992
Review
1992
Clinical risks of thrombolytic therapy.
R. Califf
,
D. Fortin
,
A. Tenaglia
,
D. Sane
American Journal of Cardiology
1992
Corpus ID: 6917571
Highly Cited
1982
Highly Cited
1982
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus
K. Iida
,
R. Mornaghi
,
V. Nussenzweig
Journal of Experimental Medicine
1982
Corpus ID: 12924129
This study reports quantitative information on the concentration of complement receptor for C3b and C4b (CR1) on erythrocytes…
Expand
Highly Cited
1976
Highly Cited
1976
Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.
F. Hay
,
L. J. Nineham
,
I. Roitt
Clinical and Experimental Immunology
1976
Corpus ID: 11886998
A new, sensitive and quantitative technique for the routine estimation of immune complexes has been devised. The assay involved…
Expand
Highly Cited
1976
Highly Cited
1976
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease.
R. Johnston
,
J. Lehmeyer
Journal of Clinical Investigation
1976
Corpus ID: 20145574
Contact between human neutrophils and aggregated immunoglobulin G bound to micropore filters has been studied as a model of the…
Expand
Highly Cited
1971
Highly Cited
1971
MECHANISMS INVOLVED IN THE DEPOSITION OF IMMUNE COMPLEXES IN TISSUES
C. Cochrane
Journal of Experimental Medicine
1971
Corpus ID: 29694886
The mechanisms reponsible for the deposition of circulating immune complexes have been analyzed. An active process appears to be…
Expand
Highly Cited
1971
Highly Cited
1971
ACUTE IMMUNE COMPLEX DISEASE IN RABBITS
P. Henson
,
C. Cochrane
Journal of Experimental Medicine
1971
Corpus ID: 17191218
By depletion of C3 from rabbits undergoing acute experimental immune complex disease with an anticomplementary factor in cobra…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE